Exploring the groundbreaking research on how gut microbiome influences COPD development and potential microbiome-targeted therapies for respiratory diseases.
Explore how Pseudomonas aeruginosa establishes chronic infections in COPD patients, its virulence mechanisms, risk factors, and emerging treatments.
Exploring the revolutionary discovery of the lung microbiome and its distinct patterns in IPF versus COPD, revealing new insights for diagnosis and treatment.
Exploring how bacterial extracellular vesicles influence asthma and COPD pathogenesis and their diagnostic potential